Hologram QSAR Studies on Farnesoid X Receptor Activators

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|3|4|261-267

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.3, Iss.4, 2006-05, pp. : 261-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hologram QSAR Studies of N,N-Dialkyl-2-phenylindol-3-ylglyoxylamides Derivatives as Selective Peripheral Benzodiazepine Receptor Ligands

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 2, 2010-02 ,pp. : 133-138

Bentham Science Publishers

Access to resources Recommend Favorite

The farnesoid X receptor: a novel drug target?

By Claudel Thierry   Sturm Ekkehard   Kuipers Folkert   Staels Bart  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1135-1148

Informa Healthcare

Access to resources Recommend Favorite

Classical and Hologram QSAR Studies on a Series of Tacrine Derivatives as Butyrylcholinesterase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 2, 2007-03 ,pp. : 106-113

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 19, 2014-10 ,pp. : 2188-2205

Bentham Science Publishers

Access to resources Recommend Favorite

Potential therapeutic applications of farnesoid X receptor (FXR) modulators

By Pellicciari Roberto   Gioiello Antimo   Costantino Gabriele  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 333-341

Informa Healthcare

Access to resources Recommend Favorite